Sanofi – Genzyme deal edges closer
February 1, 2011Sales and Marketing Genzyme, Lemtrada, Sanofi
Sanofi-Aventis has entered into a confidentiality agreement with Genzyme to discuss the prospects of Lemtrada, which suggests a deal could …
Oxford BioMedica buys decommissioned facility
February 1, 2011Manufacturing and Production Oxford BioMedica, RecipharmCobra Biologics, manufacturing
Gene therapy specialist Oxford BioMedica has said it plans to acquire a £1.9 million ($3.1m) manufacturing facility from contract manufacturer …
Tarceva set for first line treatment
January 31, 2011Sales and Marketing Iressa, NSCLC, Roche, Tarceva
Roche’s lung cancer treatment Tarceva has been shown to help patients as a first line treatment. An independent data monitoring …
UK hails high uptake of cervical cancer vaccine
January 31, 2011Research and Development Cervarix, HPV
The NHS campaign to vaccinate girls against the future risk of developing cervical cancer has been a success, according to …
AstraZeneca revenues reach standstill
January 31, 2011Sales and Marketing AstraZeneca, Full year 2010, patent expiry, results
AstraZeneca’s revenues came to a virtual standstill in 2010, with strong growth outside the US being offset by generic competition …
GSK and Actelion drop insomnia treatment
January 30, 2011Research and Development Actelion, GSK, insomnia
Actelion and GlaxoSmithKline are to abandon development of phase III insomnia drug almorexant because of problems with side-effects.Almorexant a dual …
Mitsubishi Tanabe recalls two million injectables
January 28, 2011Manufacturing and Production Mitsubishi, injectables, recall
Mitsubishi Tanabe Corp has said it will recall two million of its injectable medicines made at a facility in Ashikaga, …
Mike Paling receives outstanding contribution award
January 28, 2011Medical Communications Mike Paling, TBWA/Paling Walters, awards
Mike Paling, chief executive and chairman of TBWA\Paling Walters has received an award for Outstanding Contribution to Pharmaceutical Marketing for …
EMA road map to prioritise pharmacovigilance
January 28, 2011Research and Development, Sales and Marketing EMA, European Medicines Agency, pharmacovigilance
The European Medicines Agency is to prioritise issues such as pharmacovigilance over the next five years, while also looking closely …
Mixed picture on postcode prescribing
January 28, 2011Sales and Marketing NHS reforms, PCTs, SHAs, postcode prescribing
There are high levels of variation between Strategic Health Authorities and Primacy Care Trusts in the uptake of new drugs, …
Decision on osteoporosis drug Protelos unchanged, says NICE
January 27, 2011Sales and Marketing NICE, Protelos, Servier, osteoporotic fractures, strontium ranelate
NICE has published updated final guidance on preventing osteoporotic fractures following a reconsideration of the use of Servier’s Protelos. The …
England isn’t the sick man of Europe
January 27, 2011Kings Fund, NHS, NHS reform, king's fund
A leading health economist has questioned claims by the health secretary Andrew Lansley that England’s health is lagging behind other …
Digital Pharma: Pfizer expands European Twitter use
January 27, 2011Medical Communications Digital Pharma blog, Pfizer, Twitter
Pfizer has expanded its use of Twitter with its French operations becoming the latest of its European subsidiaries to join …
Bertil Lindmark joins Almirall as R&D head
January 27, 2011Research and Development Almirall, Bertil Lindmark, appointment, research and development
Almirall has appointed Bertil Lindmark as executive director of R&D following the retirement of Dr Per-Olof Andersson. Bertil joins the …
Lilly Oncology chief resigns
January 27, 2011Research and Development, Sales and Marketing Eli Lilly, John Johnson, Lilly Oncology, appointment, lilly, research and development, sales and marketing
Lilly has an unexpected search on its hands for someone to lead its oncology business after John Johnson unexpectedly announced …
Novartis posts strong growth but warns of tough year ahead
January 27, 2011Sales and Marketing 2010 pharma results, Novartis
Novartis has posted strong sales growth for the full year but its chief executive warns of ‘headwinds in 2011’ as …
Prime Minister uses online network to rally doctors around reforms
January 27, 2011Sales and Marketing Doctors.net.uk, GPs, commissioning, david cameron, docotrs, prime minister
Prime Minister David Cameron has made exclusive use of Doctors.net.uk, the UK’s largest network of medical professionals, to reinforce his …
NICE decides to back Abilify in schizophrenia
January 27, 2011Sales and Marketing Abilify, BMS, Bristol-Myers Squibb, NICE, Otsuka, aripiprazole, schizophrenia
NICE has changed its mind over Bristol-Myers Squibb’s and Otsuka Pharmaceuticals Abilify, deciding to recommend the drug as a schizophrenia …
Double Helix Consulting expands
January 26, 2011Sales and Marketing Clara Loveman, Double Helix, Dr Clive Whitcher, Dr Laurence Wild, appointment, sales and marketing
Double Helix Consulting has appointed three new executives to its growing global team – Clara Loveman, Dr Clive Whitcher and …
The Evolving Role of European Regulatory Agencies
January 26, 2011Research and Development Consultancy, regulatory affairs, regulatory agencies
The regulatory landscape can change in a very short period of time. Matthew Walker, Senior Regulatory Affairs Executive at TRAC …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
